LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Clinical trial NCT03049735 · COMPLETED
Trial details
- NCT number
- NCT03049735
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-26
- Primary completion
- 2019-04-29
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.